BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 34335981)

  • 21. The severity of SARS-CoV-2 infection in K18-hACE2 mice is attenuated by a novel steroid-derivative in a gender-specific manner.
    Gupte SA; Bakshi CS; Blackham E; Duhamel GE; Jordan A; Salgame P; D'silva M; Khan MY; Nadler J; Gupte R
    Br J Pharmacol; 2023 Oct; 180(20):2677-2693. PubMed ID: 37259182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models.
    Jeong H; Woo Lee Y; Park IH; Noh H; Kim SH; Kim J; Jeon D; Jang HJ; Oh J; On D; Uhm C; Cho K; Oh H; Yoon S; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Yeon Kim S; Kim YB; Hwang JY; Lee HJ; Kim HB; Jeong DG; Song D; Song M; Park MS; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Nam KT; Seong JK
    Dis Model Mech; 2022 Nov; 15(11):. PubMed ID: 36222118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age associated susceptibility to SARS-CoV-2 infection in the K18-hACE2 transgenic mouse model.
    Dwivedi V; Shivanna V; Gautam S; Delgado J; Hicks A; Argonza M; Meredith R; Turner J; Martinez-Sobrido L; Torrelles JB; Kulkarni V
    Geroscience; 2024 Jun; 46(3):2901-2913. PubMed ID: 38388916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan.
    Liu X; Mostafavi H; Ng WH; Freitas JR; King NJC; Zaid A; Taylor A; Mahalingam S
    mBio; 2022 Jun; 13(3):e0068322. PubMed ID: 35420469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice.
    Gutman H; Aftalion M; Melamed S; Politi B; Nevo R; Havusha-Laufer S; Achdout H; Gur D; Israely T; Dachir S; Mamroud E; Sagi I; Vagima Y
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mild and Severe SARS-CoV-2 Infection Induces Respiratory and Intestinal Microbiome Changes in the K18-hACE2 Transgenic Mouse Model.
    Seibert B; Cáceres CJ; Cardenas-Garcia S; Carnaccini S; Geiger G; Rajao DS; Ottesen E; Perez DR
    Microbiol Spectr; 2021 Sep; 9(1):e0053621. PubMed ID: 34378965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
    Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
    mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection.
    Gan ES; Syenina A; Linster M; Ng B; Zhang SL; Watanabe S; Rajarethinam R; Tan HC; Smith GJ; Ooi EE
    Antiviral Res; 2021 Sep; 193():105138. PubMed ID: 34246735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs.
    Won T; Wood MK; Hughes DM; Talor MV; Ma Z; Schneider J; Skinner JT; Asady B; Goerlich E; Halushka MK; Hays AG; Kim DH; Parikh CR; Rosenberg AZ; Coppens I; Johns RA; Gilotra NA; Hooper JE; Pekosz A; Čiháková D
    EBioMedicine; 2022 Jan; 75():103812. PubMed ID: 35033854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local Complement Contributes to Pathogenic Activation of Lung Endothelial Cells in SARS-CoV-2 Infection.
    Zhang H; Gerasimovskaya E; McCarthy MK; May NA; Prasad RR; Riddle S; McKeon BA; Kumar S; Li M; Hu CJ; Frid MG; Morrison TE; Stenmark KR
    Am J Respir Cell Mol Biol; 2023 Aug; 69(2):210-219. PubMed ID: 37071849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
    Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
    Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
    Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
    Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-Organ Histopathological Changes in a Mouse Hepatitis Virus Model of COVID-19.
    Paidas MJ; Mohamed AB; Norenberg MD; Saad A; Barry AF; Colon C; Kenyon NS; Jayakumar AR
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains.
    Radvak P; Kwon HJ; Kosikova M; Ortega-Rodriguez U; Xiang R; Phue JN; Shen RF; Rozzelle J; Kapoor N; Rabara T; Fairman J; Xie H
    Nat Commun; 2021 Nov; 12(1):6559. PubMed ID: 34772941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice.
    Oladunni FS; Park JG; Pino PA; Gonzalez O; Akhter A; Allué-Guardia A; Olmo-Fontánez A; Gautam S; Garcia-Vilanova A; Ye C; Chiem K; Headley C; Dwivedi V; Parodi LM; Alfson KJ; Staples HM; Schami A; Garcia JI; Whigham A; Platt RN; Gazi M; Martinez J; Chuba C; Earley S; Rodriguez OH; Mdaki SD; Kavelish KN; Escalona R; Hallam CRA; Christie C; Patterson JL; Anderson TJC; Carrion R; Dick EJ; Hall-Ursone S; Schlesinger LS; Alvarez X; Kaushal D; Giavedoni LD; Turner J; Martinez-Sobrido L; Torrelles JB
    Nat Commun; 2020 Nov; 11(1):6122. PubMed ID: 33257679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection.
    Rathnasinghe R; Strohmeier S; Amanat F; Gillespie VL; Krammer F; García-Sastre A; Coughlan L; Schotsaert M; Uccellini MB
    Emerg Microbes Infect; 2020 Dec; 9(1):2433-2445. PubMed ID: 33073694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural Killer Cells Do Not Attenuate a Mouse-Adapted SARS-CoV-2-Induced Disease in
    Ellsworth CR; Wang C; Katz AR; Chen Z; Islamuddin M; Yang H; Scheuermann SE; Goff KA; Maness NJ; Blair RV; Kolls JK; Qin X
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies.
    FitzGerald ES; Chen Y; Fitzgerald KA; Jamieson AM
    Am J Respir Cell Mol Biol; 2021 Jun; 64(6):687-697. PubMed ID: 33740387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2.
    Sánchez-Morales L; Porras N; García-Seco T; Pérez-Sancho M; Cruz F; Chinchilla B; Barroso-Arévalo S; Diaz-Frutos M; Buendía A; Moreno I; Briones V; Risalde MLÁ; de la Fuente J; Juste R; Garrido J; Balseiro A; Gortázar C; Rodríguez-Bertos A; Domínguez M; Domínguez L
    Vet Res; 2024 May; 55(1):71. PubMed ID: 38822398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function.
    Winkler ES; Bailey AL; Kafai NM; Nair S; McCune BT; Yu J; Fox JM; Chen RE; Earnest JT; Keeler SP; Ritter JH; Kang LI; Dort S; Robichaud A; Head R; Holtzman MJ; Diamond MS
    bioRxiv; 2020 Jul; ():. PubMed ID: 32676600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.